PHILADELPHIA—Thoracic paravertebral block with liposomal bupivacaine (Exparel, Pacira BioSciences) reduces total postoperative opioid consumption relative to standard bupivacaine plus dexamethasone in patients undergoing liver resection, according to the results of a new study. However, the trial found differences between groups within a number of other end points.
“Liver resection is a very painful procedure and is typically associated with a large consumption of opioids during the